No Data
No Data
BIOSINO BIO-TEC: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2024
BIOSINO BIO-TEC (08247) issued a profit warning, expecting a net loss of approximately 55 million to -60 million yuan in 2024.
BIOSINO BIO-TEC (08247) announced that the group expects to incur a net loss of approximately RMB 550... in 2024.
BIOSINO BIO-TEC: PROFIT WARNING
BIOSINO BIO-TEC: NOTICE OF BOARD MEETING
All the way up! The Innovative Drugs Sector in Hong Kong stocks surged collectively, with multiple stocks doubling this year. Who is reshaping the valuation?
The rise in the Hong Kong stock market's Innovative Drugs Sector continues. Market analysts point out that this wave of Innovative Drugs momentum benefits from a combination of factors including market sentiment, policy, and the realization of the companies' own commercial value.
The Hong Kong stock market for Medical stocks is surging! In February, the strongest has risen over 220%, what happened?
Recently, the General Office of the State Council forwarded the "2025 Action Plan for Stabilizing Foreign Investment" from the Ministry of Commerce and the National Development and Reform Commission, promoting the orderly opening of the Biomedical sector.